mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study.

Eric Yuk Fai WanCeline Sze Ling ChuiAnna Hoi Ying MokWanchun XuVincent Ka Chun YanFrancisco Tsz Tsun LaiXue LiCarlos King Ho WongEsther Wai Yin ChanDavid Tak Wai LuiKathryn Choon Beng TanIvan Fan Ngai HungCindy Lo Kuen LamGabriel Matthew LeungIan Chi Kei Ck Wong

Published in: Drug safety (2022)

Patients with T2DM do not appear to have higher risks of AESI and acute diabetic complications after BNT162b2 or CoronaVac vaccination. Moreover, given the low incidence of AESIs and acute diabetic complications after vaccination, the absolute risk increment was likely minimal.

Keyphrases

liver failure
respiratory failure
type diabetes
drug induced
wound healing
aortic dissection
coronavirus disease
risk factors
sars cov
hepatitis b virus
adipose tissue
metabolic syndrome
insulin resistance
glycemic control